- Display 15 Products per page
Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products
Published: May 23, 2013 | Price: $3,500.00 – $7,000.00
The global blood industry has experienced strong growth in recent years and although this brisk expansion will slow somewhat as products continue to mature and pricing pressures increase, growth will remain solid though 2017 as a result of aging populations in the U.S., Europe and Japan; ongoing technology advancements/new product introductions and indications; expansion of health coverage in the U.S. via health care reform; and continued strong promotion of blood donation by collection agencies. Kalorama Information's Blood: The Worldwide Market...
Brazil IVD Market Analysis
Published: June 16, 2017 | Price: $2,800.00 – $5,600.00
Brazil IVD Market Analysis Brazil IVD Market Analysis provides useful information to business planners including market size estimates for various segments, forecasts, competitive analysis, corporate profiles, market share and other information on the Brazilian laboratory market and its influences. The focus is on the IVD discipline including reagents, consumables, calibrators and controls of market segments, including: Brazil IVD Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology/Molecular, POC, Histology, Other, Total) Brazil IVD Sales by Market Segment, 2016 Market Distribution...
Bundle: Medical Imaging Markets and Medical Contrast Agent Markets Global License
Published: September 27, 2012 | Price: $12,784.00
Kalorama's Medical Contrast Agents market research report and Molecular Imaging Report for global license in one bundled offering.
Cancer Liquid Biopsy Market Assessment
Published: November 8, 2017 | Price: $2,000.00 – $4,000.00
Cancer Liquid Biopsy Market Assessment (Breast Cancer, Colorectal Cancer, Lung Cancer, Ovarian Cancer, Pancreatic Cancer) The term liquid biopsy encompasses various diagnostic methods that use liquid, non-tissue specimens to provide information that can aid in the diagnosis, treatment and monitoring of cancer. Currently, tissue biopsies, along with imaging techniques, are the standard methods used in the diagnosis of solid cancers, but despite their widespread use, they have many limitations that open the door for other diagnostic technologies in oncology clinical...
Cancer Markers
Published: March 24, 2016 | Price: $2,000.00 – $4,000.00
Cancer Markers Cancer Markers contains revenue assessment, analysis, and competitive review for tests for oncology using biomarkers. Multiple firms manufacture a range of technologies – histology/cytology, immunohistochemistry, in situ hybridization, immunoassays - tumor markers, flow cytometry, rapid tests, and molecular marker-based technologies – to determine risk for cancer, screen for cancer, test for cancer, and help in prognosis and personalization of therapy. Cancer Markers provides the following information: global cancer biomarkers diagnostic revenues, 2015 and 2020 (IHC, ISH, immunoassays, flow,...
Cancer Therapeutics: The Worldwide Market , 2nd Edition
Published: February 1, 2007 | Price: $2,500.00 – $7,990.00
With over 6,160 individual data points reflecting useful market data, Kalorama's Cancer Therapeutics: The Worldwide Market, 2nd Edition is the most comprehensive and recent information available on the five key cancer therapy and treatment markets in a syndicated market research report, including the following areas: Chemotherapy, including -Subcategories Alkylating Agents, Antimetabolites, Cytotoxic Agents, Plant Derivatives -Brands such as Elotaxin, Taxotere, Gemzar, Alimta and Temodar with Market Share for each Hormone Therapy: -Subcategories include Corticosteroids, Hormone Agonists/Antagonists, Aromatase Inhibitors and SERMS...
CAR-T Cell Therapy Market Review
Published: December 19, 2019 | Price: $4,000.00 – $8,000.00
CAR-T cell therapy is a form of immunotherapy that utilizes the body’s own T cells to target and destroy cancer cells. This therapy is a personalized form of treatment, meaning that each patient receives T cells that are geared specifically toward his or her cancer diagnosis. T-cell therapy works by removing existing T cells from a patient and having them grown and modified in a lab. These new T cells are given a gene for a specialized receptor, known as...
Cardiac Markers
Published: June 16, 2016 | Price: $1,596.00 – $3,192.00
Cardiac Markers Cardiac Markers provides market and competitive analysis for tests for cardiovascular disease (CVD) that use biomarkers, including the global CVD biomarkers diagnostic market in 2015 and 2020. The report discusses selected biomarkers and biomarker panels for CVD and the manufacturers developing and marketing these. The report also notes selected lipid biomarkers and the manufacturers developing and marketing these. Cardiac Markers notes trends in test strategies as well. Beckman Coulter, Inc. (subsidiary of Danaher Corporation), bioMérieux SA, Quest Diagnostics,...
Cardiac Rhythm Management Device Markets: Forecasts to 2020
Published: May 1, 2015 | Price: $499.00 – $1,000.00
As cardiovascular disease is the most common cause of mortality in the developed world, it is natural that a great deal of emphasis should be placed on devices used to treat advanced cardiovascular disease, particularly arrhythmias and congestive heart failure. This report, Cardiac Rhythm Device Markets, includes cardiac rhythm management devices with both external and internal applications. Major segments include defibrillators: electrical devices that deliver therapeutic levels of energy to the heart muscle for the treatment of ventricular defibrillation. pacemakers: small electrical...
Cardiovascular Disease: The 45 Market in the United States for Drugs and Medical Devices
Published: March 1, 2004 | Price: $2,995.00 – $5,990.00
Cardiovascular disease includes chronic conditions such as hypertension, congestive heart failure and atherosclerosis, as well as such acute conditions as myocardial infarction and cardiac arrest. While cardiovascular disease may be diagnosed at any age, it is most prevalent in later years, particularly among sedentary individuals who are also overweight or obese. With the aging of the "Baby Boom" generation, a generation that has defined the term "couch potato" and has grown up on and maintained a diet of fast-food, the...
Cell and Gene Therapy Business Outlook
Published: January 1, 2022 | Price:
How Do You Plan to Keep Up With Developments in The Business of Cell and Gene Therapy in 2022? Consider Cell and Gene Therapy Business Outlook Each week brings news in Cell and Gene Therapy, from advances in clinical trials to product launches, from tools development to mergers and acquisitions. It can be a daunting task to keep up. Yet these developments are too fast-moving and significant for healthcare companies of any type to ignore. Now from Science and Medicine...
Cell and Gene Therapy Deals Analysis, 2021-2024
Published: June 3, 2024 | Price: $6,300.00 – $12,600.00
Cell and Gene Therapy Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2024 is published in two installments, the first in Q2 2024 and the second in Q4 2024. Customers who purchase the report will receive both installments. Kalorama Information’s Cell and Gene Therapy Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2024 offers a comprehensive look at the dynamic and rapidly evolving cell and gene therapy market. This report highlights the significant deal-making activities that...
Cell and Gene Therapy Deals: Financings, Partnering, M&A, Technology Transfers, IPOs, and Other Developments
Published: February 16, 2022 | Price: $5,000.00 – $10,000.00
Cell and Gene Therapy Funding Reached $70 Billion in 2021. How Can You Keep Up with the Activity in this Industry? A lot of attention is being given to the areas related to cell and gene therapy (CGT) recently. There are now many approved therapies with proven track records. As the tools have lowered the barriers to entry for the industry, over a thousand companies have been created or become involved. Fortunately, Kalorama Information has been tracking every significant development in...
Cell and Gene Therapy Funding and Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2023
Published: December 8, 2023 | Price: $5,000.00 – $10,000.00
While the concepts of gene therapy and cell therapy have been investigated for decades, there were major challenges in the early years. Through incremental progress, and the gradual introduction of enabling tools such as CRISPR and next-generation sequencing (NGS), cell and gene therapy has emerged into a highly active area. There are now many approved therapies with proven track records. As the technologies have lowered the barriers to entry for the industry, over 1,500 therapy or tools companies have been...
Cell and Gene Therapy Market and Deals Analysis, 2023: Financings, Partnering, Mergers and Acquisitions, Tech Transfers, IPOs, and Other Deals
Published: May 22, 2023 | Price: $5,000.00 – $10,000.00
This report, Kalorama's Cell and Gene Deals and Market Analysis, tracks the dealmaking and market opportunity in cell and gene therapy. The report includes specific details of 1000+ deals from 2022-2023. A lot of attention is being given to the areas related to cell and gene therapy (CGT) recently. Kalorama's CGT deals amounted to a staggering $40 billion in 2022. Understanding the deals that have been made, who is making them, and what the specific details are is critical to...